Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Opinion · 24 Sep 2024 Editorial · 28 Jun 2021 GLP-1RA and DPP-4i and Heart Rat
Author(s): Johnrgronald* Full-Text PDF Select your language of interest to
Research article · 29 Nov 2020 A Disproportionality Analysis of the Risk of Rhabdomyolysis Associated with DPP-4 Inhibitors in the Food and Drug Administration Adverse Event Reporting System
Backgrounds: Dipeptidyl peptidase 4 inhibitors (DPP4is) are widely used in patients with
Research article · 30 Sep 2020 Air-made, Flexible, Schottky Junction Diode Using DPP-DTT Co-polymer System
Conference abstract · 28 May 2018 Low-voltage organic field-effect transistors based on diketopyrrolopyrrole (DPP) copolymer using selfassembled monolayers-Passivated HfOx dielectrics
High performance organic field effect transistors (OFETs) operating at low-voltages (Vop
Short communication · 2 Mar 2018 Treatment of type 2 diabetes, GLP-1 Agonist and a DPP-4 Inhibitor
Review article · 2017 The Difference between SGLT2 and DPP-4 Inhibitors on Glucose Fluctuation in Patients with Type 2 Diabetes
Various oral and parental hypoglycemic agents have been developed to achieve adequate
Research article · 2014 Pioglitazone Increases Serum DPP-4 Level in Type 2 Diabetes Mellitus
Conference abstract · 2014 Dipeptidyl peptidase IV (CD26/DPP-IV) inhibitory and cryptoprotective role of some antidiabetic plants
Conference abstract · 23 Oct 2013 Lactic acid bacteria as potential bio-therapeutic agents of type 2 Diabetes: Stimulation of incretin hormone and inhibition of DPP IV
Incretins are a group gut hormones (GLP-1 and GIP) which play
Research article · 2011 2D QSAR Analysis on 5β-Methylprolyl-2-Cyanopyrrolidine Derivatives as DPP IV Inhibitors
Article · 2009 DIPEPTIDYL PEPTIDASE-4 INHIBITORS: A NEWAPPROACH IN DIABETES TREATMENT
cell protection with insulin sensitisers may improve the prognosis of diabetes. Dipeptidyl peptidase-4 (DPP-4) is the enzyme responsible for inactivating the incretin hormones glucagon-like peptide ... peptidase 4 is a…
Research article · 3 May 2019 Design of New Inhibitors of Dipeptidyl Peptidase-4 in Type 2 Diabetes by Computer Simulations
mode of interaction of a ligand with its receptor. Inhibition of Dipeptidyl Peptidase-4 “DPP-4” is an important approach in the treatment of disease in Type 2 diabetes. Several ... them being a pharmacological…
Review article · 20 Oct 2016 Incretin-based therapies and cancer risk: a review of recent literature safety data
market of the first GLP-1 receptor agonist, exenatide, and the first inhibitor of DPP-4, sitagliptin. These drugs act throughout the potentiation of incretin receptor signalling. Today, other ... receptor agonists and 4…
Research article · 2013 MOLECULAR DOCKING STUDY ON DIPEPTIDYL PEPTIDASE-4 INHIBITORS
Dipeptidyl peptidase (DPP)-IV inhibitors are a new approach to the treatment of type 2 diabetes. DPP-IV is a member of a family of serine peptidases that includes quiescent ... cell proline dipeptidase (QPP), DPP8, and…
Research article · Sep 2013 Dipeptidyl Peptidase–IV: A Brief Review
NIDDM/T2D] is a metabolic disorder that is characterized by Insulin resistance and hyperglycemia. DPP IV inhibitors have been investigated as new target for T2D treatment. DPP IV inhibition improves ... Treatment of…
Research article · 2012 Expression Pattern of OCT-4 and PLZF Transcription Factors during the Early Events of Spermatogenesis in Mice
expression of Oct-4 and Plzf in the testes of 10 days post partum (dpp) mice compared to 5 dpp both at the transcription and translation levels. The expression ... found to be maximum in 10 dpp, declined in 20 dpp and…
Short communication · 19 Jun 2021 The National Diabetes Prevention Program
National Diabetes Prevention Program—or National DPP—was created in 2010 to address the increasing burden of prediabetes and type 2 diabetes in the United States. This national effort created ... diabetes in communities…
Short communication · 29 Mar 2021 Target approach in diabetes prophylaxis
particular, to improve the process of protein synthesis. The NIDDK-sponsored Diabetes Prevention Program (DPP) and ongoing DPP Outcomes Study (DPPOS) are major studies that changed the way people approach ... type 2…
Conference abstract · 13 Nov 2019 Synthesis, structural characterization and docking studies of sulfamoylphenyl acid esters as dipeptidyl peptidase-IV inhibitors
several serious complications including retinopathy, neuropathy, nephropathy and macrovascular diseases. Dipeptidyl peptidase-IV (DPP-IV) inhibitors, gliptins, are a new class of antidiabetic agents that potentiates the…
Research article · 3 May 2019 Mini-review: Pharmacokinetics of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor
dipeptidyl peptidase-4 (DPP-4) inhibitors are novel oral hypoglycemic drugs which have been in clinical use for the past 10 years. The drugs are safe, weight neutral and widely ... effects profile. The currently…
Conference abstract · 14 Nov 2016 Study of extracellular enzymes of Pediococcus acidilactici: An approach towards understanding of action molecules of Probiotics
which was also confirmed by genome mining studies using bioinformatics. DPP-II, an exopeptidase was purified and characterized. This was 38.7 KDa homodimer that worked optimally ... retained more than 90% activity at…
Conference abstract · 14 Sep 2016 Enzymes of peptide and purine metabolism in a neuroinflammation mechanism in neurodegenerative pathology
change in both inflammation and neurodegeneration. Dipeptidyl peptidase IV (adenosine deaminase (ADA) binding protein, DPP-4) and related peptidases hydrolyze cytokines, neuropeptides and immunopeptides. In our…

